Stay updated on BLD-2660 in IPF: Safety, PK, PD Clinical Trial
Sign up to get notified when there's something new on the BLD-2660 in IPF: Safety, PK, PD Clinical Trial page.

Latest updates to the BLD-2660 in IPF: Safety, PK, PD Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov record for the BLD-2660 study in idiopathic pulmonary fibrosis is displayed, with details on its design, participants, interventions, outcomes, and record dates. It identifies the study as withdrawn due to patient-safety concerns during the COVID-19 crisis.SummaryDifference55%

- Check11 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAn NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the inaccessible study record. The site revision identifier also changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check39 days agoChange DetectedThe site footer’s revision number changed from v3.7.0 to v3.7.1; the page continues to display a 403 error.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now displays a 403 Forbidden error page with a simple header and a Home link, replacing the previously visible study details.SummaryDifference20%

- Check60 days agoChange DetectedThe page’s revision indicator was updated from v3.6.6 to v3.7.0, signaling a platform/template update. No study-specific content or data changes are indicated by this update.SummaryDifference0.1%

Stay in the know with updates to BLD-2660 in IPF: Safety, PK, PD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BLD-2660 in IPF: Safety, PK, PD Clinical Trial page.